We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$889M
AUM Growth
+$286M
Cap. Flow
+$257M
Cap. Flow %
28.9%
Top 10 Hldgs %
5.11%
Holding
1,751
New
702
Increased
366
Reduced
206
Closed
467

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.25%
2 Healthcare 14.82%
3 Industrials 14.28%
4 Financials 11.09%
5 Technology 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
1126
McKesson
MCK
$102B
$225K 0.03%
+1,174
New +$227K
MSI icon
1127
Motorola Solutions
MSI
$78.5B
$225K 0.03%
+1,037
New +$207K
NEWT icon
1128
NewtekOne
NEWT
$432M
$224K 0.03%
+6,420
New +$202K
THFF icon
1129
First Financial Corp
THFF
$981M
$224K 0.03%
5,484
+939
+21% +$41.7K
AMRN
1130
Amarin Corp
AMRN
$301M
$223K 0.03%
+2,541
New +$250K
FARO
1131
DELISTED
Faro Technologies
FARO
$223K 0.03%
+2,862
New +$225K
SCHW
1132
Charles Schwab
SCHW
$187B
$222K 0.03%
+3,043
New +$215K
CWCO icon
1133
Consolidated Water Co
CWCO
$479M
$221K 0.02%
+18,820
New +$233K
GEVO icon
1134
Gevo
GEVO
$351M
$221K 0.02%
30,421
+15,639
+106% +$114K
INO icon
1135
Inovio Pharmaceuticals
INO
$69.6M
$220K 0.02%
1,976
-71
-3% -$6.82K
XP icon
1136
XP
XP
$8.62B
$220K 0.02%
+5,043
New +$209K
BKR icon
1137
Baker Hughes
BKR
$62.3B
$219K 0.02%
+9,575
New +$221K
VRTX icon
1138
Vertex Pharmaceuticals
VRTX
$123B
$219K 0.02%
+1,087
New +$227K
BCS icon
1139
Barclays
BCS
$95B
$218K 0.02%
+22,600
New +$231K
PSMT icon
1140
Pricesmart
PSMT
$5.5B
$218K 0.02%
+2,398
New +$214K
XYZ
1141
Block Inc
XYZ
$47.5B
$218K 0.02%
+894
New +$207K
NNN icon
1142
NNN REIT
NNN
$9.02B
$217K 0.02%
+4,623
New +$216K
CAL icon
1143
Caleres
CAL
$486M
$216K 0.02%
7,921
-20,852
-72% -$523K
CLX icon
1144
Clorox
CLX
$12.8B
$216K 0.02%
1,200
-1,261
-51% -$230K
GOLF icon
1145
Acushnet Holdings
GOLF
$5.5B
$216K 0.02%
4,382
-2,002
-31% -$96.2K
IMDX
1146
Insight Molecular Diagnostics
IMDX
$155M
$216K 0.02%
1,882
-349
-16% -$34.1K
RAMP icon
1147
LiveRamp
RAMP
$2.3B
$216K 0.02%
+4,616
New +$222K
UI icon
1148
Ubiquiti
UI
$34.3B
$216K 0.02%
+692
New +$203K
PSNL icon
1149
Personalis
PSNL
$1.39B
$215K 0.02%
+8,516
New +$195K
HNGR
1150
DELISTED
Hanger Inc.
HNGR
$215K 0.02%
+8,522
New +$212K

Similar funds

GSA Capital Partners's Q2 2021 Portfolio in Review

As of Q2 2021, GSA Capital Partners held 1,751 positions worth $889M, up 47% from $603M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

GSA Capital Partners deployed $257M of net new capital in Q2 2021, opening 702 new positions and adding to 366 existing holdings. Its largest new stake was Vapotherm, Inc. Common Stock: 22,078 shares worth $4.17M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Baidu, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q2 2021 buy was Vapotherm, Inc. Common Stock: 22,078 shares worth $4.17M.
  • GSA Capital Partners added most to Meta Platforms (Facebook) in Q2 2021, an estimated $3.9M increase.
  • GSA Capital Partners's biggest Q2 2021 reduction was Baidu, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited Vipshop in Q2 2021, selling an estimated $4.82M.
  • GSA Capital Partners's ten largest holdings make up 5.1% of its $889M portfolio in Q2 2021.
  • GSA Capital Partners opened 702 new positions and closed 467 in Q2 2021.
  • GSA Capital Partners's portfolio value rose 47% quarter-over-quarter to $889M.

Based on GSA Capital Partners's 13F filing for Q2 2021, filed 5 Aug 2021.